AIMM Therapeutics BV-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:AIMM Therapeutics BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011836
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AIMM Therapeutics BV (AIMM Therapeutics) is a biotechnology company that develops progressive approach to the discovery of therapeutic antibodies for the treatment of cancer and infectious diseases. The company offers research programs for prevention and treatment of diseases with medical needs which include cancer, infectious, inflammatory and autoimmune diseases. It sources antibodies from individual patients and a non-human species. The company offers licensing of antibodies and platform licensing services. It partners with research communities and commercial companies for antibody discovery. AIMM Therapeutics is headquartered in Amsterdam, the Netherlands.

AIMM Therapeutics BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AIMM Therapeutics BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
AIMM Acquires IBIS-MX96 System From IBIS Technologies 10
Partnerships 11
AIMM Therapeutics Enters Into Co-Development Agreement With Cosmo Pharma 11
Licensing Agreements 12
Merck Enters into Licensing And Option Agreement with AIMM Therapeutics 12
AIMM Therapeutics BV – Key Competitors 13
AIMM Therapeutics BV – Key Employees 14
AIMM Therapeutics BV – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Key Facts 2
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
AIMM Therapeutics BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
AIMM Therapeutics BV, Deals By Therapy Area, 2011 to YTD 2017 8
AIMM Therapeutics BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
AIMM Acquires IBIS-MX96 System From IBIS Technologies 10
AIMM Therapeutics Enters Into Co-Development Agreement With Cosmo Pharma 11
Merck Enters into Licensing And Option Agreement with AIMM Therapeutics 12
AIMM Therapeutics BV, Key Competitors 13
AIMM Therapeutics BV, Key Employees 14

★海外企業調査レポート[AIMM Therapeutics BV-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PetroFrontier Corp. (PFC)(石油・ガス分野):企業M&A動向
    Summary PetroFrontier Corp. (PetroFrontier) is an oil and gas exploration company. The company explores, acquires and develops conventional and unconventional onshore petroleum and natural gas. It holds interests in four exploration permits and two exploration permit applications in the Northern Ter …
  • Global Energy Development PLC (GED):企業の財務及び戦略的SWOT分析
    Summary Global Energy Development PLC (Global Energy) an oil and gas company that offers petroleum production and development services. The company’s activities include production, development drilling and exploration of properties. It develops, produces, and sells hydrocarbons in South America. Glo …
  • PhilWeb Corporation (WEB):企業財務及び戦略的SWOT分析
    Summary PhilWeb Corporation (PhilWeb), formerly South Seas Natural Resources Inc. is a technology company that provides gaming technology. The company concentrates its activities on building internet-based products and services. Its information technology services delivers hardware, software, networ …
  • NovaMed Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NovaMed Pharmaceuticals, Inc. M …
  • Barclays Bank PLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Barclays Bank PLC Mergers and A …
  • Vance Publishing Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Vance Publishing Corporation Me …
  • China Green Agriculture, Inc. (formerly Discovery Technologies, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' China Green Agriculture, Inc. ( …
  • Enbridge Energy Partners, L.P. (EEP):企業のM&A・提携動向(石油・ガス分野)
    Summary Enbridge Energy Partners, L.P. (EEP) is an independent midstream energy company. The company owns and operates crude oil and liquid petroleum transportation and storage assets, and natural gas gathering, treating, processing, transportation and marketing assets in the US. Its portfolio of as …
  • Janssen Pharmaceutica N.V.:企業のM&A・提携動向(医療機器分野)
    Summary Janssen Pharmaceutica N.V. (Janssen Pharmaceutica), a subsidiary of Janssen Global Services, LLC is a pharmaceutical company that discovers, develops and supplies medicinal drugs. The company offers products which include human medicine products, veterinary products, and preservation and mat …
  • Central Foods Limited:企業概要およびSWOT分析
    Summary Canadean's "Central Foods Limited : Foodservice - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company hist …
  • Arakawa Chemical Industries, Ltd. (4968):企業概要、財務及び戦略的SWOT分析
    Summary Arakawa Chemical Industries, Ltd. (Arakawa Chemical) is a chemical company. The company manufactures and markets various chemical products to different customers. It offers products through its departments such as paper chemicals department, specialty chemicals department, electronic materia …
  • Cantex Mine Development Corporation (CD):企業概要、財務及び戦略的SWOT分析
    Summary Cantex Mine Development Corporation (Cantex) is a mineral exploration service provider. The company acquires, explores and develops mineral properties for commercial mineral deposits. Its project in northwestern Yemen owns exploration licenses. Cantex’s secondary project is in Nevada, the US …
  • Terumo Corporation (4543):企業のM&A・提携動向(医療機器分野)
    Summary Terumo Corporation (Terumo) is a medical technology company. It undertakes the manufacturing and selling of a wide range of medical care products which include hospital and medical products, equipment and pharmaceuticals. Its major products include vascular interventional products, cardiovas …
  • Lotte Chemical Corp (011170):企業の財務・戦略的SWOT分析
    Lotte Chemical Corp (011170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Trimble Navigation Limited:企業のM&A・提携・投資分析
    Trimble Navigation Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Trimble Navigation Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • TAG Oil Ltd. (TAO):企業の財務及び戦略的SWOT分析
    Summary TAG Oil Ltd. (TAG Oil) is an oil and gas company that explores, develops and produces natural gas and crude oil. The company has oil and gas properties in Taranaki Basin and East Coast Basin. Its Taranaki Basin is located on the North Island of New Zealand. TAG Oil’s Cretaceous-Cenozoic fore …
  • Edge Therapeutics, Inc.(製薬・医療分野):企業M&A動向
    Summary Edge Therapeutics, Inc. (Edge Therapeutics) is a clinical-stage biotechnology company. The company discovers, develops and commercializes hospital-based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neurological conditions for which limite …
  • Ligand Pharmaceuticals Inc (LGND)-製薬・医療分野:企業M&A・提携分析
    Summary Ligand Pharmaceuticals Inc (Ligand) develops and acquires technologies that help in discovery and development of medicines. The company provides a diversified portfolio of biotechnology and pharmaceutical products. Its marketed product portfolio encompasses indication for fungal infections, …
  • J.M. Huber Corporation:企業のM&A・提携動向(石油・ガス分野)
    Summary J.M. Huber Corporation (Huber), through its subsidiaries, provides hydrocolloids, specialty engineered woods, specialty ingredients and minerals. The company offers wide range of hydrocolloids products that include gellan gum, xanthan gum, pectin and other specialty biopolymers. Its special …
  • Gas Natural SDG S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gas Natural SDG S.A. Mergers an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆